Elizabeth Anderson
Stock Analyst at Evercore ISI Group
(2.53)
# 2,401
Out of 5,072 analysts
134
Total ratings
54.22%
Success rate
-1.16%
Average return
Main Sectors:
Stocks Rated by Elizabeth Anderson
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| PRVA Privia Health Group | Maintains: Outperform | $28 → $30 | $24.38 | +23.05% | 5 | Nov 7, 2025 | |
| OMDA Omada Health | Maintains: Outperform | $27 → $28 | $18.74 | +49.41% | 1 | Nov 7, 2025 | |
| DOCS Doximity | Maintains: Outperform | $81 → $70 | $51.44 | +36.08% | 10 | Nov 7, 2025 | |
| HSIC Henry Schein | Maintains: Outperform | $83 → $90 | $74.57 | +20.69% | 2 | Nov 5, 2025 | |
| CAH Cardinal Health | Maintains: Outperform | $190 → $220 | $212.26 | +3.65% | 10 | Oct 31, 2025 | |
| TDOC Teladoc Health | Maintains: In-Line | $9 → $8 | $7.59 | +5.40% | 6 | Oct 30, 2025 | |
| CVS CVS Health | Maintains: Outperform | $85 → $95 | $80.36 | +18.22% | 10 | Oct 30, 2025 | |
| ALGN Align Technology | Maintains: Outperform | $160 → $170 | $147.19 | +15.50% | 15 | Oct 30, 2025 | |
| XRAY DENTSPLY SIRONA | Maintains: In-Line | $17 → $13 | $11.34 | +14.64% | 8 | Oct 8, 2025 | |
| IQV IQVIA Holdings | Maintains: Outperform | $220 → $240 | $230.01 | +4.34% | 7 | Oct 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $60 → $65 | $48.91 | +32.90% | 2 | Oct 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: In-Line | $4 → $3 | $2.99 | +0.33% | 9 | Oct 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: In-Line | $7 → $11 | $12.72 | -13.52% | 10 | Oct 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: In-Line | $185 → $190 | $189.18 | +0.43% | 4 | Oct 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $300 → $305 | $268.78 | +13.48% | 7 | Oct 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $800 → $825 | $881.12 | -6.37% | 7 | Sep 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $19 → $23 | $20.90 | +10.05% | 4 | Jul 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: In-Line | $5 → $3 | $0.65 | +360.76% | 5 | Jul 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $32 → $36 | $36.91 | -2.47% | 4 | Nov 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: In-Line | $68 → $26 | $2.99 | +777.93% | 3 | Mar 16, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: In-Line | $35 → $15 | $4.10 | +266.30% | 3 | Mar 2, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: In-Line | $11 | $1.45 | +658.62% | 2 | Jan 4, 2022 |
Privia Health Group
Nov 7, 2025
Maintains: Outperform
Price Target: $28 → $30
Current: $24.38
Upside: +23.05%
Omada Health
Nov 7, 2025
Maintains: Outperform
Price Target: $27 → $28
Current: $18.74
Upside: +49.41%
Doximity
Nov 7, 2025
Maintains: Outperform
Price Target: $81 → $70
Current: $51.44
Upside: +36.08%
Henry Schein
Nov 5, 2025
Maintains: Outperform
Price Target: $83 → $90
Current: $74.57
Upside: +20.69%
Cardinal Health
Oct 31, 2025
Maintains: Outperform
Price Target: $190 → $220
Current: $212.26
Upside: +3.65%
Teladoc Health
Oct 30, 2025
Maintains: In-Line
Price Target: $9 → $8
Current: $7.59
Upside: +5.40%
CVS Health
Oct 30, 2025
Maintains: Outperform
Price Target: $85 → $95
Current: $80.36
Upside: +18.22%
Align Technology
Oct 30, 2025
Maintains: Outperform
Price Target: $160 → $170
Current: $147.19
Upside: +15.50%
DENTSPLY SIRONA
Oct 8, 2025
Maintains: In-Line
Price Target: $17 → $13
Current: $11.34
Upside: +14.64%
IQVIA Holdings
Oct 8, 2025
Maintains: Outperform
Price Target: $220 → $240
Current: $230.01
Upside: +4.34%
Oct 8, 2025
Maintains: Outperform
Price Target: $60 → $65
Current: $48.91
Upside: +32.90%
Oct 8, 2025
Maintains: In-Line
Price Target: $4 → $3
Current: $2.99
Upside: +0.33%
Oct 8, 2025
Maintains: In-Line
Price Target: $7 → $11
Current: $12.72
Upside: -13.52%
Oct 8, 2025
Maintains: In-Line
Price Target: $185 → $190
Current: $189.18
Upside: +0.43%
Oct 3, 2025
Maintains: Outperform
Price Target: $300 → $305
Current: $268.78
Upside: +13.48%
Sep 24, 2025
Maintains: Outperform
Price Target: $800 → $825
Current: $881.12
Upside: -6.37%
Jul 9, 2025
Maintains: Outperform
Price Target: $19 → $23
Current: $20.90
Upside: +10.05%
Jul 9, 2025
Maintains: In-Line
Price Target: $5 → $3
Current: $0.65
Upside: +360.76%
Nov 7, 2024
Maintains: Outperform
Price Target: $32 → $36
Current: $36.91
Upside: -2.47%
Mar 16, 2022
Maintains: In-Line
Price Target: $68 → $26
Current: $2.99
Upside: +777.93%
Mar 2, 2022
Downgrades: In-Line
Price Target: $35 → $15
Current: $4.10
Upside: +266.30%
Jan 4, 2022
Downgrades: In-Line
Price Target: $11
Current: $1.45
Upside: +658.62%